[Updated] UK SACT Board: Good Practice Guidance for Immuno-Oncology Medicines

UK SACT Board

 

Good Practice Guidance for Immuno-Oncology Medicines – May 2024

The UK SACT Board’s Good Practice Guidance for Immuno-Oncology Medicines has been updated.

This guideline is designed to give a practical framework for the safe introduction and ongoing use of immunotherapy in existing Systemic Anti-Cancer Therapy (SACT) services.

This guideline is available on the UK SACT Board publication page: https://www.uksactboard.org/publications

Latest News

By BOPA Research Committee on 21st November 2024

National survey about the implementation of JDBS/UK chemo board guidelines on the management of glycaemia in people with cancer

National survey about the implementation of JDBS/UK chemo board guidelines on the management of glycaemia in people with cancer. The purpose is to understand some of the enablers and barriers…

Read article
By BOPA Committee on 18th November 2024

ISOPP CAPhO Symposium 2025

ISOPP CAPhO Symposium 2025 (ISOPP CAPhO 2025) is taking place April 3-6 (Symposium) and April 7 (Masterclasses) at the Victoria Conference Centre, Victoria, British Columbia, Canada. The Symposium is hosted…

Read article
By BOPA Education and Training Subcommittee on 18th November 2024

Project to link members to MPharm course in the UK

Dear BOPA Members, The Education & Training subcommittee are working on a project to link BOPA members into every undergraduate MPharm course in the UK, with the aim of providing…

Read article
By EDI Subcommittee on 8th November 2024

BOPA EDI membership survey

We invite you to take part in a quick BOPA EDI membership survey. Your responses will assist the BOPA Equity, Diversity and Inclusion (EDI) subcommittee to better serve the membership…

Read article